I
IsoRay Inc
XBER:AAJ
IsoRay Inc
XBER:AAJ
Price:
11.1
EUR
Market Cap:
€470.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
IsoRay Inc
XBER:AAJ
|
US |
|
ONE Gas Inc
NYSE:OGS
|
US |
|
Storskogen Group AB (publ)
STO:STOR B
|
SE |
|
Charter Hall Group
ASX:CHC
|
AU |
|
Hoth Therapeutics Inc
NASDAQ:HOTH
|
US |
|
Frencken Group Ltd
SGX:E28
|
MY |
|
Compass Minerals International Inc
NYSE:CMP
|
US |
|
G
|
Global Battery Metals Ltd
OTC:REZZF
|
CA |
|
P
|
Pureprofile Ltd
ASX:PPL
|
AU |
|
Westpac Banking Corp
ASX:WBC
|
AU |
|
Squarespace Inc
NYSE:SQSP
|
US |
|
Sumitomo Pharma Co Ltd
TSE:4506
|
JP |
|
With us Corp
TSE:9696
|
JP |
|
M
|
Metro Retail Stores Group Inc
XPHS:MRSGI
|
PH |
|
Manchester United PLC
NYSE:MANU
|
UK |
|
Jiangsu Azure Corp
SZSE:002245
|
CN |
|
Allison Transmission Holdings Inc
NYSE:ALSN
|
US |
|
N
|
National United Resources Holdings Ltd
HKEX:254
|
HK |
|
Jammu and Kashmir Bank Ltd
NSE:J&KBANK
|
IN |
|
M
|
Mason Capital Corp
KOSDAQ:021880
|
KR |
|
Carmila SA
PAR:CARM
|
FR |
|
E
|
Embellence Group AB (publ)
STO:EMBELL
|
SE |
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
AU |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of AAJ.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AAJ
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
AAJ Competitors Multiples
IsoRay Inc Competitors
IsoRay Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
I
|
IsoRay Inc
XBER:AAJ
|
470.6m EUR | 91.8 | -6.9 | -5 | -4.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
366.3B USD | 6.1 | 88.5 | 14.7 | 20.4 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.4B USD | 109.7 | -1 713.1 | 15 914.4 | -1 797 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.8B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.6B USD | 5.8 | 20.1 | 12.6 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.6B USD | 9.6 | 29.3 | 22 | 23 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.6 | 17.8 | 13.2 | 15.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68B AUD | 3.2 | 35.2 | 11.6 | 14.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
